Motomi (Tomi) Mori

Professor

  • 10333 Citations
  • 54 h-Index
1988 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Motomi (Tomi) Mori is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • OREGON CANCER CENTER

    Mori, M. (., Corless, C., Beer, T. (., McWeeney, S., Harrington, C. (., Bagby, G., Druker, B., Sexton, G., Hall, A., Henner, W., Samuels, M. H., Bakke, A., Hoatlin, M., Baetscher, M., Keller, T., Nagalla, S., Magun, B. E., Koop, D. R., Mauro, M. J., Blanke, C. D., Bakke, A., Baetscher, M., Koop, D., Spellman, P., David, L., Coussens, L., Streeter, P., Thomas, G., Mori, M. (., Mori, M. (., Harrington, C. (., Bergan, R. & Blanke, C.

    National Institutes of Health

    8/1/976/30/17

    Project: Research project

  • Research Output

    Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia

    Eide, C. A., Kurtz, S. E., Kaempf, A., Long, N., Agarwal, A., Tognon, C. E., Mori, M., Druker, B. J., Chang, B. H., Danilov, A. V. & Tyner, J. W., Jan 1 2020, (Accepted/In press) In : Leukemia.

    Research output: Contribution to journalArticle

  • Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial

    Zhang, Z., Garzotto, M., Davis, E. W., Mori, M., Stoller, W. A., Farris, P. E., Wong, C. P., Beaver, L. M., Thomas, G. V., Williams, D. E., Dashwood, R. H., Hendrix, D. A., Ho, E. & Shannon, J., Jan 2 2020, In : Nutrition and Cancer. 72, 1, p. 74-87 14 p.

    Research output: Contribution to journalArticle

  • Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk

    Goddard, E. T., Bassale, S., Schedin, T., Jindal, S., Johnston, J., Cabral, E., Latour, E., Lyons, T. R., Mori, M., Schedin, P. J. & Borges, V. F., Jan 4 2019, In : JAMA Network Open. 2, 1, p. e186997

    Research output: Contribution to journalArticle

    Open Access
  • 9 Scopus citations

    CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells

    Edwards, D. K., Watanabe-Smith, K., Rofelty, A., Damnernsawad, A., Laderas, T., Lamble, A., Lind, E. F., Kaempf, A., Mori, M., Rosenberg, M., d’Almeida, A., Long, N., Agarwal, A., Sweeney, D. T., Loriaux, M., McWeeney, S. K. & Tyner, J. W., Feb 7 2019, In : Blood. 133, 6, p. 588-599 12 p.

    Research output: Contribution to journalArticle

  • 10 Scopus citations

    Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma

    Spurgeon, S. E., Sharma, K., Claxton, D. F., Ehmann, C., Pu, J., Shimko, S., Stewart, A., Subbiah, N., Palmbach, G., LeBlanc, F., Latour, E., Chen, Y. Y., Mori, M., Hasanali, Z. & Epner, E. M., Sep 1 2019, In : British Journal of Haematology. 186, 6, p. 845-854 10 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations